Takeshi Ninchoji

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome

Naohiro Kamiyoshi, Kandai Nozu, Xue Jun Fu et al. · Clinical Journal of the American Society of Nephrology · 2016 · 129 citations · Full text

Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin

Ross Smith, Takeshi Ninchoji, Emma Gordon et al. · eLife · 2020 · 106 citations · Full text

Pathology, Retinal Therapies, Vegfr2 Y949 +17

Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome

Tomohiko Yamamura, Tomoko Horinouchi, China Nagano et al. · Kidney International · 2020 · 101 citations · Full text

Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo–Bartter/Gitelman syndrome based on clinical characteristics

Natsuki Matsunoshita, Kandai Nozu, Akemi Shono et al. · Genetics in Medicine · 2015 · 89 citations · Full text

Differential Diagnosis, Diagnosis, Pseudo–bartter/gitelman Syndrome +3

Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain

Yuya Hashimura, Kandai Nozu, Hiroshi Kaito et al. · Kidney International · 2013 · 88 citations

X-linked Alport Syndrome, Pathology, Milder Clinical Aspects +4